Skip to main content
Fig. 3 | Clinical Proteomics

Fig. 3

From: A clinical perspective on the utility of alpha 1 antichymotrypsin for the early diagnosis of calcific aortic stenosis

Fig. 3

Validation of the AACT protein using IHC. Stronger expression of AACT is observed in the endothelium on the aortic side and, to a greater extent in the fibrosa of the stenotic valves when compared to the controls. DAB staining is brown and is indicated by the arrows. Statistical analyses showed significant differences (*p = 0.023). Amplified images at ×100 magnification

Back to article page

Clinical Proteomics

ISSN: 1559-0275